Integra LifeSciences
IART
144 hedge funds and large institutions have $1.18B invested in Integra LifeSciences in 2014 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 51 increasing their positions, 50 reducing their positions, and 15 closing their positions.
26% more call options, than puts
Call options by funds: $1.82M | Put options by funds: $1.44M
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
2% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 50
0% more funds holding
Funds holding: 144 → 144 (0)
2% less capital invested
Capital invested by funds: $1.21B → $1.18B (-$25.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$13.8M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$4.62M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$4.19M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.82M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Barings
Charlotte,
North Carolina
|
-$6.01M |
| 2 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$5.97M |
| 3 |
DM
Deerfield Management
New York
|
-$3.11M |
| 4 |
GACM
Green Arrow Capital Management
New York
|
-$2.96M |
| 5 |
Goldman Sachs
New York
|
-$2.76M |
IART Hedge Fund Activity: Q1 2014 in Review
144 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2014, worth a combined $1.18B — down 2.1% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IART positions and 15 closed out — a net gain of 2 holders — while 51 added to existing stakes and 50 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $13.8M. The largest seller was Barings, exiting entirely with an estimated $6.01M sold.
- 144 institutional investors held Integra LifeSciences (IART) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $1.18B of Integra LifeSciences stock for Q1 2014, down 2.1% quarter-over-quarter.
- 17 funds opened new Integra LifeSciences positions in Q1 2014 and 15 closed out, a net change of +2 holders.
- The largest Integra LifeSciences buyer in Q1 2014 was OppenheimerFunds, an estimated $13.8M added.
- The largest Integra LifeSciences seller in Q1 2014 was Barings, an estimated $6.01M sold.
Based on aggregated 13F filings for Q1 2014.